Insilico Medicine

BenevolentAI (AMS: BAI) creates and applies AI and machine learning to update the way medicines are discovered and developed. Benevolent integrates its technology into …

Deargen develops Dr. UG, an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. The software specializes in genome data analysis, …

Terray Therapeutics is a biotechnology company. The company has developed a novel screening and optimization platform (tArray) to develop invent treatments for intracta…

Variational AI is a Vancouver, British Colombia-based company leveraging artificial intelligence to help develop new small molecule drugs.

Exscientia (NASDAQ: EXAI) is an AI-driven, drug discovery, and design enterprise. Exscientia aims to use AI to discover and design better quality drugs with greater eff…

XtalPi is a cloud-based technology company that solves drug polymorphism by providing accurate computational crystal structure prediction for small-molecule drugs.

POLARISqb is a biotech drug design firm that develops a comprehensive IP portfolio of drug assets for license to pharma, creating a consistent revenue stream. POLARISqb…

Deep Genomics develops individualized genetic medicines by creating AI systems that are used to accelerate all steps of drug discovery and development, including target…

Standigm is an AI and systems biology-based startup that aims to expedite the drug discovery process. Standigm develops a computer modeling technology that learns medic…

AliveX Biotech is a biotechnology company in China that applies AI+ system immunology to clinical practice.

PharmCADD develops Pharmulator, a computer-aided drug discovery and development platform that utilizes computational science methodologies, advanced machine learning te…

Recursion (NASDAQ: RXRX) is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a parallel system to ef…

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created t…

Pepper Bio integrates phosphoproteomics, proteomics, transcriptomics, and genomics to develop oncology solutions.

nference offers a platform that enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. nference ma…

Atomwise uses deep learning neural networks to help discover new medicines. Atomwise achieves results for new drug hit discovery, binding affinity prediction, and toxic…

Numerate is a privately held biotechnology company that applies machine-learning algorithms, at cloud scale, to overcome major challenges in small molecule drug discove…

InSilicoTrials.com is a web-based platform, which provides a user-friendly computational modeling and simulation environment where many integrated easy-to-use in silico…

Cyclica is a global biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's structure…

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company that discovers and develops novel small molecule therapies for complex and hard-to-treat diseases

GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at th…

Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Its AI drug discovery platform le…

Innoplexus applies its proprietary tech stack in all stages of the drug development value chain via smart Data as a Service and Continuous Analytics as a Service soluti…

BERG is a Boston-based biopharma company focused on taking a bold "back to biology" approach to therapeutic discovery using its unique AI-based Interrogative Biology pl…